Literature DB >> 23782161

Hospital outbreak of Middle East respiratory syndrome coronavirus.

Abdullah Assiri1, Allison McGeer, Trish M Perl, Connie S Price, Abdullah A Al Rabeeah, Derek A T Cummings, Zaki N Alabdullatif, Maher Assad, Abdulmohsen Almulhim, Hatem Makhdoom, Hossam Madani, Rafat Alhakeem, Jaffar A Al-Tawfiq, Matthew Cotten, Simon J Watson, Paul Kellam, Alimuddin I Zumla, Ziad A Memish.   

Abstract

BACKGROUND: In September 2012, the World Health Organization reported the first cases of pneumonia caused by the novel Middle East respiratory syndrome coronavirus (MERS-CoV). We describe a cluster of health care-acquired MERS-CoV infections.
METHODS: Medical records were reviewed for clinical and demographic information and determination of potential contacts and exposures. Case patients and contacts were interviewed. The incubation period and serial interval (the time between the successive onset of symptoms in a chain of transmission) were estimated. Viral RNA was sequenced.
RESULTS: Between April 1 and May 23, 2013, a total of 23 cases of MERS-CoV infection were reported in the eastern province of Saudi Arabia. Symptoms included fever in 20 patients (87%), cough in 20 (87%), shortness of breath in 11 (48%), and gastrointestinal symptoms in 8 (35%); 20 patients (87%) presented with abnormal chest radiographs. As of June 12, a total of 15 patients (65%) had died, 6 (26%) had recovered, and 2 (9%) remained hospitalized. The median incubation period was 5.2 days (95% confidence interval [CI], 1.9 to 14.7), and the serial interval was 7.6 days (95% CI, 2.5 to 23.1). A total of 21 of the 23 cases were acquired by person-to-person transmission in hemodialysis units, intensive care units, or in-patient units in three different health care facilities. Sequencing data from four isolates revealed a single monophyletic clade. Among 217 household contacts and more than 200 health care worker contacts whom we identified, MERS-CoV infection developed in 5 family members (3 with laboratory-confirmed cases) and in 2 health care workers (both with laboratory-confirmed cases).
CONCLUSIONS: Person-to-person transmission of MERS-CoV can occur in health care settings and may be associated with considerable morbidity. Surveillance and infection-control measures are critical to a global public health response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23782161      PMCID: PMC4029105          DOI: 10.1056/NEJMoa1306742

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  29 in total

1.  Using models to identify routes of nosocomial infection: a large hospital outbreak of SARS in Hong Kong.

Authors:  Kin On Kwok; Gabriel M Leung; Wai Yee Lam; Steven Riley
Journal:  Proc Biol Sci       Date:  2007-03-07       Impact factor: 5.349

2.  Estimating incubation period distributions with coarse data.

Authors:  Nicholas G Reich; Justin Lessler; Derek A T Cummings; Ron Brookmeyer
Journal:  Stat Med       Date:  2009-09-30       Impact factor: 2.373

3.  Severe respiratory illness associated with a novel coronavirus--Saudi Arabia and Qatar, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-10-12       Impact factor: 17.586

4.  Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-08-27       Impact factor: 17.586

5.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

6.  Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

Authors:  A Bermingham; M A Chand; C S Brown; E Aarons; C Tong; C Langrish; K Hoschler; K Brown; M Galiano; R Myers; R G Pebody; H K Green; N L Boddington; R Gopal; N Price; W Newsholme; C Drosten; R A Fouchier; M Zambon
Journal:  Euro Surveill       Date:  2012-10-04

7.  Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction.

Authors:  V M Corman; I Eckerle; T Bleicker; A Zaki; O Landt; M Eschbach-Bludau; S van Boheemen; R Gopal; M Ballhause; T M Bestebroer; D Muth; M A Müller; J F Drexler; M Zambon; A D Osterhaus; R M Fouchier; C Drosten
Journal:  Euro Surveill       Date:  2012-09-27

8.  Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.

Authors:  Sander van Boheemen; Miranda de Graaf; Chris Lauber; Theo M Bestebroer; V Stalin Raj; Ali Moh Zaki; Albert D M E Osterhaus; Bart L Haagmans; Alexander E Gorbalenya; Eric J Snijder; Ron A M Fouchier
Journal:  MBio       Date:  2012-11-20       Impact factor: 7.867

Review 9.  Incubation periods of acute respiratory viral infections: a systematic review.

Authors:  Justin Lessler; Nicholas G Reich; Ron Brookmeyer; Trish M Perl; Kenrad E Nelson; Derek A T Cummings
Journal:  Lancet Infect Dis       Date:  2009-05       Impact factor: 25.071

Review 10.  The management of coronavirus infections with particular reference to SARS.

Authors:  Samson S Y Wong; Kwok-Yung Yuen
Journal:  J Antimicrob Chemother       Date:  2008-06-18       Impact factor: 5.790

View more
  622 in total

1.  Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.

Authors:  Kumari G Lokugamage; Krishna Narayanan; Keisuke Nakagawa; Kaori Terasaki; Sydney I Ramirez; Chien-Te K Tseng; Shinji Makino
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Perceptions of postoutbreak management by management and healthcare workers of a Middle East respiratory syndrome outbreak in a tertiary care hospital: a qualitative study.

Authors:  Bandar Abdulmohsen Al Knawy; Hanan M F Al-Kadri; Mahmoud Elbarbary; Yaseen Arabi; Hanan H Balkhy; Alex Clark
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

3.  Underlying trend, seasonality, prediction, forecasting and the contribution of risk factors: an analysis of globally reported cases of Middle East Respiratory Syndrome Coronavirus.

Authors:  Omar B Da'ar; Anwar E Ahmed
Journal:  Epidemiol Infect       Date:  2018-06-11       Impact factor: 2.451

Review 4.  Opportunities and challenges in modeling emerging infectious diseases.

Authors:  C Jessica E Metcalf; Justin Lessler
Journal:  Science       Date:  2017-07-14       Impact factor: 47.728

5.  Middle East respiratory syndrome.

Authors:  Amal Al-Maani; Wayne L Gold; Allison McGeer
Journal:  CMAJ       Date:  2015-04-20       Impact factor: 8.262

6.  Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.

Authors:  Kristen E Pascal; Christopher M Coleman; Alejandro O Mujica; Vishal Kamat; Ashok Badithe; Jeanette Fairhurst; Charleen Hunt; John Strein; Alexander Berrebi; Jeanne M Sisk; Krystal L Matthews; Robert Babb; Gang Chen; Ka-Man V Lai; Tammy T Huang; William Olson; George D Yancopoulos; Neil Stahl; Matthew B Frieman; Christos A Kyratsous
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 7.  Fast vaccine design and development based on correlates of protection (COPs).

Authors:  Cécile van Els; Siri Mjaaland; Lisbeth Næss; Julia Sarkadi; Eva Gonczol; Karen Smith Korsholm; Jon Hansen; Jørgen de Jonge; Gideon Kersten; Jennifer Warner; Amanda Semper; Corine Kruiswijk; Fredrik Oftung
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.

Authors:  Xian-Chun Tang; Sudhakar S Agnihothram; Yongjun Jiao; Jeremy Stanhope; Rachel L Graham; Eric C Peterson; Yuval Avnir; Aimee St Clair Tallarico; Jared Sheehan; Quan Zhu; Ralph S Baric; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

9.  Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response.

Authors:  Kam-Leung Siu; Man Lung Yeung; Kin-Hang Kok; Kit-San Yuen; Chun Kew; Pak-Yin Lui; Chi-Ping Chan; Herman Tse; Patrick C Y Woo; Kwok-Yung Yuen; Dong-Yan Jin
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 10.  Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus.

Authors:  Anthony R Fehr; Rudragouda Channappanavar; Stanley Perlman
Journal:  Annu Rev Med       Date:  2016-08-26       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.